MJP Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
MJP Associates's PFE Position: Q1 2026 in Review
MJP Associates increased its Pfizer (PFE) stake by 2.4% in Q1 2026, buying an estimated $14.5K and bringing the position to 23,682 shares worth $665K. The position accounts for 0.08% of the portfolio, ranked #83.
MJP Associates first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.17M in Q2 2022. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- MJP Associates held 23,682 shares of Pfizer worth $665K as of Q1 2026.
- MJP Associates bought 545 Pfizer shares in Q1 2026, an estimated $14.5K.
- Pfizer made up 0.08% of MJP Associates's portfolio in Q1 2026, its #83 holding.
- MJP Associates first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- MJP Associates's Pfizer position peaked at $1.17M in Q2 2022.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on MJP Associates's 13F filing for Q1 2026, filed 5 May 2026.